Skip to main content
ES
v1.2
Log in
L

Lupin

LUPINNSE
₹1,961.6-19.30 (-0.97%)as of 2026-10-16
Market Cap
₹90,899Cr.
P/E Ratio
15.3
P/B Ratio
4.00
EPS (TTM)
₹128.21
Day Range
₹1,947 – ₹1,980.5
Div Yield
0.92%
ROCE
29.9%
ROE
28.7%
52W Low: ₹1,90052W High: ₹2,530
Themes:💊 Pharma & CDMO
Appears in 1 screen
💠Quality at a Reasonable Price
89
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 19.0% a year over three years.
  • Debt is 0.29× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Lupin — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Upper third
7/ 10Overall
7/ 10Valuation
9/ 10Quality
5/ 10Fundamental
7/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 15.3P/E: 15.3 | P/B: 4.00
Growth
GrowingSales CAGR — 3Y: 19% · 1Y: 28%
Profitability
High MarginROCE: 29.9% | ROE: 28.7%

Key Metrics

Valuation
PEG Ratio 0.11
Price / Sales 3.03x
Price / FCF 16.4x
Book Value ₹491
Margins & returns
Operating Margin 32%
Net Margin 18.5%
Return on Assets 14.6%

Frequently Asked Questions

MarketsPortfolioChart